OPALINE : A Study Of Morbidity And Mortality At 2 Years

NCT02264665 · clinicaltrials.gov ↗

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive

Interventions

DRUG: sunitinib
DRUG: everolimus
DRUG: chemotherapies recommended in france

Sponsor

Pfizer

Collaborators

[object Object]
[object Object]